In this study, we comprehensively summarized the roles of PPAR synthetic ligands in current clinical applications or studies for the treatment of T2DM, DN, obesity, CVDs, MS, AD, gout, cancer, PBC, UC et al., as shown in Figure 2. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.